THERMO ELECTRON CORP
S-3, 1996-12-12
MEASURING & CONTROLLING DEVICES, NEC
Previous: STATE STREET BOSTON CORP, 8-K, 1996-12-12
Next: TIFFANY & CO, 10-Q, 1996-12-12











    As filed with the Securities and Exchange Commission on December 12, 1996
                                            Registration No. 333-_______

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                    FORM S-3
                             Registration Statement
                                      Under
                           The Securities Act of 1933

                           THERMO ELECTRON CORPORATION
             (Exact name of registrant as specified in its charter)
                               __________________

             Delaware                                0-2209186
        (State or other jurisdiction of         (I.R.S. Employer 
        incorporation or organization)          Identification No.) 

                                 81 Wyman Street
                                  P.O. Box 9046
                             Waltham, MA 02254-9046
                                 (617) 622-1000
          (Address, including zip code, and telephone number, including
             area code, of registrant's principal executive offices)

                                Sandra L. Lambert
                           Thermo Electron Corporation
                                 81 Wyman Street
                                 P. O. Box 9046
                             Waltham, MA  02254-9046
                                 (617) 622-1000
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)


                                   Copies to:
        Seth H. Hoogasian, Esquire         Edwin L. Miller, Jr., Esquire
        General Counsel                     Testa, Hurwitz & Thibeault
        Thermo Electron Corporation             Exchange Place
        81 Wyman Street                    125 High Street 
        P.O. Box 9046                      High Street Tower
        Waltham, Massachusetts 02254-9046  Boston, Massachusetts 02109 


                             ----------------------

        Approximate date of commencement of proposed sale to the public:  As
   soon as practicable after the Registration Statement has become effective.
PAGE
<PAGE>






        If the only securities being registered on this form are being offered
   pursuant to dividend or interest reinvestment plans, please check the
   following box.   [   ]

        If any of the securities being registered on this form are to be
   offered on a delayed or continuous
   basis pursuant to Rule 415 under the Securities Act of 1933, other than
   securities offered only in connection with dividend or interest
   reinvestment plans, check the following box.   [  x ] 

        If this Form is filed to register additional securities for an
   offering pursuant to Rule 462(b) under the Securities Act, please check the
   following box and list the Securities Act registration statement number of
   the earlier effective registration statement for the same offering. [    ]

        If this Form is a post-effective amendment filed pursuant to Rule
   462(b) under the Securities Act, check the following box and list the
   Securities Act registration statement number of the earlier effective
   registration statement for the same offering.  [   ]

        If delivery of the prospectus is expected to be made pursuant to Rule
   434, please check the following box. [   ]

                         CALCULATION OF REGISTRATION FEE


                                    Proposed   Proposed
   Title of each classAmount to be  maximum    maximum      Amount of
   of securities to beRegistered    offering   aggregate    registration
   registered                       price per  offering     fee
                                    share (1)  price (1)

   Common Stock,      5,000,000     $34.94     $174,700,000 $52,939.40
   $1.00 par value... shs. 


   (1)  Estimated solely for the purpose of calculating the registration fee
   pursuant to Rule 457(c) under the Securities Act of 1933 based upon the
   average of the high and low prices of the Common Stock on the New York
   Stock Exchange on December 6, 1996.
   _________________________

        The Registrant hereby amends this Registration Statement on such date
   or dates as may be necessary to delay its effective date until the
   Registrant shall file a further amendment which specifically states that
   this Registration Statement shall thereafter become effective in accordance
   with Section 8(a) of the Securities Act of 1933 or until this Registration
   Statement shall become effective on such date as the Commission, acting
   pursuant to said Section 8(a), may determine.
PAGE
<PAGE>





   P R O S P E C T U S                                      5,000,000 SHARES

                           THERMO ELECTRON CORPORATION

                                  Common Stock

                            PAR VALUE $1.00 Per Share
                              ____________________

        This Prospectus relates to the delivery of  up to 5,000,000 shares
   (the "Shares") of common stock, par value $1.00 per share (the "Common
   Stock"), of Thermo Electron Corporation (the "Company") by Thermo
   Instrument Systems Inc. ("Thermo Instrument"), an 81.3%-owned subsidiary of
   the Company, to holders of Thermo Instrument's 4 1/2% Senior Convertible
   Debentures due 2003 (the "Debentures"), upon conversion of the Debentures
   and upon the exercise of the Settlement Option (as defined below) by Thermo
   Instrument.  The Debentures are convertible, prior to redemption or
   maturity, into shares of Thermo Instrument common stock at a conversion
   price of $43.07 per share, subject to adjustment under certain conditions
   and subject to Thermo Instrument's option to deliver, in lieu of all or a
   portion of the shares of Thermo Instrument common stock into which the
   Debentures are convertible, Shares having a Thermo Electron Market Price
   (as defined under "Plan of Distribution") equal to the Market Price (as
   defined under "Plan of Distribution") of such shares of Thermo Instrument
   common stock (the "Settlement Option").  The Debentures are guaranteed by
   the Company.  

        The Shares will be sold by the Company to Thermo Instrument pursuant
   to a plan adopted by the Board of Directors of the Company (the "Plan").
   Under the Plan, Thermo Instrument may purchase for cash from time to time
   at its election Shares at a price per share equal to the average of the
   closing sale prices of the Common Stock on the New York Stock Exchange on
   the five trading days preceding the date upon which Thermo Instrument
   notifies the Company of its intent to purchase Shares.  Thermo Instrument
   may only purchase Shares for purposes of delivery pursuant to the
   Settlement Option.

        The Company has agreed to bear all expenses (other than underwriting
   discounts and selling commissions, and fees and expenses of counsel or
   other advisors to the sellers of the Shares) in connection with the
   registration and sale of the Shares being registered hereby.  The Company
   has agreed to indemnify Thermo Instrument against certain liabilities,
   including liabilities under the Securities Act as underwriter or otherwise.


                             ----------------------
PAGE
<PAGE>





        THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE
    SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR
       HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
    COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS.  ANY
              REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
                             ______________________

        No dealer, salesman or other person has been authorized to give any
   information or to make any representations other than those contained or
   incorporated by reference in this Prospectus regarding the Company or the
   offering made by this Prospectus, and, if given or made, such information
   or representations must not be relied upon as having been authorized by the
   Company or by any other person.  All information contained in this
   Prospectus is as of the date of this Prospectus.  Neither the delivery of
   this Prospectus nor any sale or distribution and resale made hereunder
   shall, under any circumstances, create any implication that there has been
   no change in the affairs of the Company since the date hereof.  This
   Prospectus does not constitute an offer to sell or a solicitation of any
   offer to buy any security other than the securities covered by this
   Prospectus, nor does it constitute an offer to or solicitation of any offer
   to buy any security other than the securities covered by this Prospectus,
   nor does it constitute an offer to or solicitation of any person in any
   jurisdiction in which such offer or solicitation may not be lawfully made.
                          ____________________________
   December 12, 1996
PAGE
<PAGE>







                              AVAILABLE INFORMATION

             The Company is subject to the informational requirements of
        the Securities Exchange Act of 1934, as amended (the "Exchange
        Act"), and in accordance therewith files reports, proxy
        statements and other information with the Securities and Exchange
        Commission (the "Commission").  Reports, proxy statements and
        other information filed by the Company with the Commission can be
        inspected and copied at the public reference facilities
        maintained by the Commission at Room 104, Judiciary Plaza, 450
        Fifth Street, N.W., Washington, D.C. 20549 or at its regional
        offices located at 500 West Madison Street, Chicago, Illinois
        60661, and Seven World Trade Center, 13th Floor,  New York, New
        York 10048.  Copies of such material can be obtained from the
        Public Reference Section of the Commission at 450 Fifth Street,
        N.W., Washington, D.C. 20549 at prescribed rates.  The Commission
        also maintains a Web site that contains reports, proxy and
        information statements and other information regarding
        registrants that file electronically with the Commission,
        including the Company.  The address of such site is
        http://www.sec.gov.  The Common Stock of the Company is listed on
        the New York Stock Exchange (the "NYSE"), and the reports, proxy
        statements and other information filed by the Company with the
        Commission can be inspected at the office of the NYSE, 20 Broad
        Street, New York, New York 10005.

             This Prospectus, which constitutes part of a registration
        statement (herein, together with all exhibits thereto, referred
        to as the "Registration Statement") filed by the Company with the
        Commission under the Securities Act of 1933 (the "Securities
        Act"), omits certain of the information contained in the
        Registration Statement. Reference is hereby made to the
        Registration Statement for further information with respect to
        the Company and the securities offered hereby.

             The Company undertakes to provide without charge to each
        person to whom a copy of this Prospectus has been delivered, on
        the written or oral request of such person, a copy of any or all
        of the documents that have been or may be incorporated in this
        Prospectus by reference, other than exhibits to such documents.
        Requests for such copies should be directed to:  Sandra L.
        Lambert, Secretary, Thermo Electron Corporation, 81 Wyman Street,
        P.O. Box 9046, Waltham, Massachusetts 02254-9046 (telephone
        number: (617-622-1000).









                                        3
PAGE
<PAGE>






                                TABLE OF CONTENTS


        Available Information  ......................................2
        The Company  ................................................3
        Plan of Distribution  .......................................3
        Selling Shareholders  .......................................4
        Incorporation of Documents by Reference  ....................4
        Legal Opinion  ..............................................5
        Experts  ....................................................5










































                                        4
PAGE
<PAGE>





                                   THE COMPANY

             The Company develops, manufactures and markets analytical
        and environmental-monitoring instruments, alternative-energy
        systems, industrial process equipment, biomedical products and
        various devices based on advanced technologies.  The Company also
        provides metallurgical heat-treating, environmental engineering
        and analytical laboratory services.  The Company conducts its
        business through its divisions and wholly owned subsidiaries, as
        well as majority-owned subsidiaries that are partially owned by
        the public or by private investors.

             The Company, a Delaware corporation, was incorporated in
        1956, completed its initial public offering in 1967 and was
        listed on the New York Stock Exchange in 1980.  The principal
        executive office of the Company is located at 81 Wyman Street,
        Waltham, Massachusetts 02254-9046 (telephone 617-622-1000).

                              PLAN OF DISTRIBUTION


             The Shares will be delivered by Thermo Instrument to holders
        of the Debentures upon conversion of the Debentures and upon the
        exercise of the Settlement Option by Thermo Instrument.  The
        Debentures are convertible, prior to redemption or maturity, into
        shares of Thermo Instrument common stock at a conversion price of
        $43.07 per share, subject to adjustment under certain conditions
        and subject to Thermo Instrument's option to deliver, in lieu of
        all or a portion of the shares of Thermo Instrument common stock
        into which the Debentures are convertible, Shares having a Thermo
        Electron Market Price (as defined below) equal to the Market
        Price (as defined below) of such shares of Thermo Instrument
        common stock.

             The Shares will be sold by the Company to Thermo Instrument
        pursuant to a plan adopted by the Board of Directors of the
        Company.  Under the Plan, Thermo Instrument may purchase for cash
        from time to time at its election Shares at a price per share
        equal to the average of the closing sale prices of the Common
        Stock on the New York Stock Exchange on the five trading days
        preceding the date upon which Thermo Instrument notifies the
        Company of its intent to purchase Shares.  Thermo Instrument may
        only purchase Shares for purposes of delivery pursuant to the
        Settlement Option.

             "Market Price" means either (a) if the conversion date is
        (i) a date prior to the date on which Thermo Instrument gives
        notice of redemption of all (but not less than all) of the
        Debentures (the "Redemption Notice Date") or (ii) a date on or
        after the Redemption Notice Date and Thermo Instrument has not
        specified in its redemption notice that it will exercise the
        Settlement Option with respect to all or a portion of the shares
        of Thermo Instrument common stock deliverable upon conversion of
        Debentures presented for conversion on or after the Redemption
        Notice Date, the closing sale price of the Thermo Instrument
                                        5
PAGE
<PAGE>





        common stock on such conversion date, or if the date is not a
        Stock Trading Day (as defined below), on the Stock Trading Day
        next preceding such date, as reported on the principal national
        or regional United States securities exchange on which such
        shares are traded or, if the Thermo Instrument common stock is
        not listed or admitted to trading on a United States national or
        regional securities exchange, as reported by the National
        Association of Securities Dealers Automated Quotation System
        ("NASDAQ") or by the National Quotation Bureau Incorporated, or
        (b) if the conversion date occurs on or after the Redemption
        Notice Date and Thermo Instrument has specified in its redemption
        notice that it will exercise the Settlement Option with respect
        to all or a portion of the shares of Thermo Instrument common
        stock deliverable upon conversion of Debentures presented for
        conversion on or after the Redemption Notice Date, the Weighted
        Average Price of the Thermo Instrument common stock over all of
        the Stock Trading Days falling within the 20-day period
        commencing on the Redemption Notice Date.  The "Weighted Average
        Price" of a share of common stock during any period means the
        weighted average per share sale price for all reported sales of
        such common stock on the Stock Trading Days included within such
        period (or, if the information necessary to calculate such
        weighted average per share sale price is not available, the
        average of the high and low sale prices or, if only one sale is
        reported, such sale price) as reported in composite transactions
        on the principal national or regional United States securities
        exchange on which such shares are traded or, if such common stock
        is not listed or admitted to trading on a United States national
        or regional securities exchange, as reported by NASDAQ or by the
        National Quotation Bureau Incorporated.  In the absence of such
        quotations, Thermo Instrument shall be entitled to determine the
        Weighted Average Price on the basis of such quotations as it
        considers appropriate.  A "Stock Trading Day" means each day on
        which the securities exchange or quotation system which is used
        to determine the Weighted Average Price is open for trading or
        quotation and on which at least one trade of the common stock has
        occurred.

             "Thermo Electron Market Price" means either (a) if the
        conversion date is (i) a date prior to the Redemption Notice Date
        or (ii) a date on or after the Redemption Notice Date and Thermo
        Instrument has not specified in its redemption notice that it
        will exercise the Settlement Option with respect to all or a
        portion of the shares of Thermo Instrument common stock
        deliverable upon conversion of Debentures presented for
        conversion on or after the Redemption Notice Date, the closing
        sale price of the Common Stock on such conversion date, or if the
        date is not a Stock Trading Day, on the Stock Trading Day next
        preceding such date, as reported on the principal national or
        regional securities exchange on which such shares are traded or,
        if the Common Stock is not listed or admitted to trading on a
        United States national or regional securities exchange, as
        reported by NASDAQ or by the National Quotation Bureau
        Incorporated, or (b) if the conversion date occurs on or after
        the Redemption Notice Date and Thermo Instrument has specified in
                                        6
PAGE
<PAGE>





        its redemption notice that it will exercise the Settlement Option
        with respect to all or a portion of the shares of Thermo
        Instrument common stock deliverable upon conversion of Debentures
        presented for conversion on or after the Redemption Notice Date,
        the Weighted Average Price of the Common Stock over all of the
        Stock Trading Days falling within the 20-day period commencing on
        the Redemption Notice Date.

                              SELLING SHAREHOLDERS

             As of September 28, 1996, the Company owned 81.3% of the
        outstanding common stock of Thermo Instrument, the selling
        shareholder.  Certain of the directors and officers of the
        Company are also directors and officers of Thermo Instrument.
        Thermo Instrument owns no shares of the Common Stock of the
        Company.  The Company has agreed to issue up to 5,000,000 shares
        of Common Stock to Thermo Instrument solely for issuance by
        Thermo Instrument to holders of the Debentures upon exercise by
        Thermo Instrument of the Settlement Option.   Therefore, any
        Shares acquired by Thermo Instrument pursuant to the Plan will
        promptly be delivered to holders of Debentures, and will not be
        held by Thermo Instrument other than pending such delivery.

                     INCORPORATION OF DOCUMENTS BY REFERENCE

             The following documents previously filed with the Commission
        are incorporated in this Prospectus by reference:

             (1)  The Company's Annual Report on Form 10-K for the fiscal
                  year ended December 30, 1995, as amended on Form 10-K/A
                  dated September 6, 1996.

             (2)  The Company's Quarterly Report on Form 10-Q for the
                  fiscal quarter ended March 30, 1996, as amended on Form
                  10-Q/A dated September 6, 1996.

             (3)  The Company's Quarterly Report on Form 10-Q for the
                  fiscal quarter ended June 29, 1996, as amended on Form
                  10-Q/A dated September 6, 1996.

             (4)  The Company's Quarterly Report on Form 10-Q for the
                  fiscal quarter ended September 28, 1996.

             (5)  The Company's Current Report on Form 8-K dated January
                  3, 1996.

             (6)  The Company's Current Report on Form 8-K dated January
                  19, 1996.

             (7)  The Company's Current Report on Form 8-K dated April
                  16, 1996.

             (8)  The Company's Current Report on Form 8-K dated October
                  24, 1996, as amended on Form 8-K/A dated November 12,
                  1996.
                                        7
PAGE
<PAGE>






             (9)  The description of the Company's Common Stock contained
                  in the Company's Registration Statement on Form 8-A, as
                  amended.

             All reports and other documents subsequently filed by the
        Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
        Exchange Act, prior to the termination of this offering shall be
        deemed to be incorporated by reference herein and to be part
        hereof from the date of the filing of such reports and documents.

             Statements in documents incorporated by reference herein
        shall be deemed modified by statements herein.  Statements so
        modified shall constitute part of this Prospectus only as so
        modified.

                                  LEGAL OPINION

             Certain legal matters relating to the Shares of Common Stock
        have been passed upon for the Company by Seth H. Hoogasian,
        General Counsel of  the Company.  Mr. Hoogasian owns or has the
        right to acquire 115,927 shares of Common Stock and 180,287
        shares of the common stock of the Company's subsidiaries.

                                     EXPERTS

             The financial statements and schedule of the Company for the
        year ended December 30, 1995, incorporated in this Registration
        Statement by reference to the Company's Annual Report on Form
        10-K/A for the year ended December 30, 1995 have been audited by
        Arthur Andersen LLP, independent public accountants, to the
        extent and for the periods as indicated in their reports with
        respect thereto, and are incorporated herein in reliance upon the
        authority of said firm as experts in giving said reports.





















                                        8
PAGE
<PAGE>







                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

        Item 14.  Other Expenses of Issuance and Distribution.

             The expenses (other than the underwriting discount) incurred
        by the Company in connection with the issuance and distribution
        of the securities being registered (including the securities
        which may be issued pursuant to an over-allotment option) are as
        follows:

                                                               Amount*
                                                               -------
        Securities and Exchange Commission Registration Fee  $ 52,939 
        New York Stock Exchange listing fee  ................  25,650
        Legal fees and expenses  ............................   5,000
        Accounting fees and expenses  .......................   5,000
        Miscellaneous  ......................................   1,411 
             Total  .........................................$ 90,000
        _______________
             * All amounts are estimated except the Securities and
             Exchange Commission fee and the New York Stock Exchange
             listing fee.


        Item 15.  Indemnification of Directors and Officers.

             The Delaware General Corporation Law and the Company's
        Certificate of Incorporation and By-Laws limit the monetary
        liability of directors to the Company and to its stockholders and
        provide for indemnification of the Company's officers and
        directors for liabilities and expenses that they may incur in
        such capacities.  In general, officers and directors are
        indemnified with respect to actions taken in good faith in a
        manner reasonably believed to be in, or not opposed to, the best
        interests of the Company, and with respect to any criminal action
        or proceeding, actions that the indemnitee had no reasonable
        cause to believe were unlawful.  The Company also has
        indemnification agreements with its directors and officers that
        provide for the maximum indemnification allowed by law. 

             Thermo Electron Corporation has an insurance policy which
        insures the directors and officers of Thermo Electron and its
        subsidiaries against certain liabilities which might be incurred
        in connection with the performance of their duties. 

        Item 16.  Exhibits.

             See the Exhibit Index included immediately preceding the
        exhibits to this Registration Statement.

                                        9
PAGE
<PAGE>






        Item 17.  Undertakings.

             (a)  The undersigned Registrant hereby undertakes:

                  (1)  To file, during any period in which offers or 
                  sales are being made, a post-effective amendment to thi
                  sregistration statement:

                       (i)       To include any prospectus required by
                                 Section 10(a)(3) of the Securities Act
                                 of 1933; 

                       (ii)      To reflect in the prospectus any facts
                                 or events arising after the effective
                                 date of the registration statement (or
                                 the most recent post-effective amendment
                                 thereof) which,  individually or in the
                                 aggregate, represent a fundamental
                                 change in the  information set forth in
                                 the registration statement;

                       (iii)     To include any material information with
                                 respect to the plan of distribution not
                                 previously disclosed in the registration
                                 statement or any material change to such
                                 information in the registration
                                 statement; 

             Provided, however, that paragraphs (a) (1) (i) and (a)
        (1)(ii) do not apply if the registration is on Form S-3 or Form
        S-8, and the information required to be included in a
        post-effective amendment by those paragraphs is contained in
        periodic reports filed by the Registrant pursuant to Section 13
        or Section 15(d) of the Securities Exchange Act of 1934 that are
        incorporated by reference in the registration statement.

                  (2)  That, for the purpose of determining any liability
                  under the Securities Act of 1933, each such
                  post-effective amendment shall be deemed to be a new
                  registration statement relating to the securities
                  offered therein, and the offering of such securities at
                  that time shall be deemed to be the initial bona fide
                  offering thereof. 

                  (3)  To remove from registration by means of
                  post-effective amendment any of the securities being
                  registered which remain unsold at the termination of
                  the offering.

             (b)  The undersigned Registrant hereby undertakes that, for
             purposes of determining any liability under the Securities
             Act of 1933, each filing of the Registrant's annual report
             pursuant to Section 13(a) or Section 15(d) of the Securities
             Exchange Act of 1934 (and, where applicable, each filing of
                                       10
PAGE
<PAGE>





             an employee benefit plan's annual report pursuant to Section
             15(d) of the Securities Exchange Act of 1934) that is
             incorporated by reference in the registration statement
             shall be deemed to be a new registration statement relating
             to the securities offered therein, and the offering of such
             securities at that time shall be deemed to be the initial
             bona fide offering thereof.

             (c)  Insofar as indemnification for liabilities arising
             under the Securities Act of 1933 may be permitted to
             directors, officers and controlling persons of the
             registrant pursuant to the foregoing provisions, or
             otherwise, the registrant has been advised that in the
             opinion of the Securities and Exchange Commission such
             indemnification is against public policy as expressed in the
             Act and is, therefore, unenforceable.  In the event that a
             claim for indemnification against such liabilities (other
             than the payment by the registrant of expenses incurred or
             paid by a director, officer or controlling person of the
             registrant of expenses incurred or paid by a director,
             officer or controlling person of the registrant in the
             successful defense of any action, suit or proceeding) is
             asserted by such director, officer or controlling person in
             connection with the securities being registered, the
             registrant will, unless in the opinion of its counsel the
             matter has been settled by controlling precedent, submit to
             a court of appropriate jurisdiction the question whether
             such indemnification by it is against public policy as
             expressed in the Act and will be governed by the final
             adjudication of such issue.

























                                       11
PAGE
<PAGE>





                                   SIGNATURES

             Pursuant to the requirements of the Securities Act of 1933,
        the Registrant certifies that it has reasonable grounds to
        believe that it meets all of the requirements for filing on Form
        S-3 and has duly caused this Registration Statement to be signed
        on its behalf by the undersigned, thereunto duly authorized, in
        the City of Waltham, Commonwealth of Massachusetts, on the 12th
        day of  December, 1996.

                                           THERMO ELECTRON CORPORATION

                                      By:  /s/George N. Hatsopoulos    
                                           George N. Hatsopoulos
                                           Chairman of the Board,
                                           President and Chief 
                                           Executive Officer

                                POWER OF ATTORNEY

             KNOW ALL MEN BY THESE PRESENTS that each individual whose
        signature appears below constitutes and appoints John N.
        Hatsopoulos, Paul F. Kelleher, Seth H. Hoogasian, Sandra L.
        Lambert and Jonathan W. Painter, and each of them, as his true
        and lawful attorneys-in-fact and agents for the undersigned, with
        full power of substitution, for and in the name, place and stead
        of the undersigned, to sign and file with the Securities and
        Exchange Commission under the Securities Act of 1933 any and all
        amendments and exhibits to this Registration Statement and any
        and all applications and other documents to be filed with the
        Securities and Exchange Commission pertaining to the registration
        of the securities covered hereby, with full power and authority
        to do and perform any and all acts and things whatsoever
        requisite and necessary or desirable.

             Pursuant to the requirements of the Securities Act of 1933,
        this Registration Statement has been signed by the following
        persons in the capacities and on the dates indicated.


        Signature                  Title               Date


        /s/ George N. Hatsopoulos  Chairman of the     December 12, 1996
        -------------------------
        George N. Hatsopoulos      Board, President,
                                   Chief Executive
                                   OFficer and
                                   Director

        /s/ John N. Hatsopoulos    Executive Vice      December 12, 1996
        -----------------------
        John N. Hatsopoulos        President and Chief
                                   Financial Officer
                                   (principal finance
                                   officer)

                                       12
PAGE
<PAGE>






        /s/ Paul F. Kelleher       Vice President,     December 12, 1996
        --------------------
        Paul F. Kelleher           Finance (principal
                                   accounting officer)


        /s/ John M. Albertine      Director            December 12, 1996
        ---------------------
        John M. Albertine


        /s/ Peter O. Crisp         Director            December 12, 1996
        ------------------
        Peter O. Crisp


        /s/ Elias P. Gyftopoulos   Director            December 12, 1996
        ------------------------
        Elias P. Gyftopoulos


        /s/ Frank Jungers          Director            December 12, 1996
        -----------------
        Frank Junger



        /s/ Robert A. McCabe       Director            December 12, 1996
        --------------------
        Robert A. McCabe


        /s/ Frank E. Morris        Director            December 12, 1996
        -------------------
        Frank E. Morris


        /s/ Donald E. Noble        Director            December 12, 1996
        -------------------
        Donald E. Noble


        /s/ Huthan S. Olayan       Director            December 12, 1996
        --------------------
        Hutham S. Olayan


        /s/ Roger D. Wellington    Director            December 12, 1996
        -----------------------
        Roger D. Wellington
















                                       13
PAGE
<PAGE>







                                  EXHIBIT INDEX


        Exhibit No.                   Description of Exhibit

             5                   Opinion of Seth H. Hoogasian, Esq.

             23.1                Consent of Arthur Andersen LLP

             99                  Stock Option Agreement Between
                                 Thermo Instrument Systems Inc. 
                                 and Thermo Electron Corporation

















































                                                               EXHIBIT  5


                           THERMO ELECTRON CORPORATION
                                 81 Wyman Street
                             Waltham, MA 02254-9046
                                 (617) 622-1000







                                           December 12, 1996



        VIA EDGAR TRANSMISSION
        ----------------------

        Securities and Exchange Commission
        Judiciary Plaza
        450 Fifth Street, N.W.
        Washington, D.C. 20549

             Re:  Registration Statement on Form S-3
                  Relating to 5,000,000 Shares of Common Stock,
                  Par Value $1.00 Per Share,
                  of Thermo Electron Corporation
                  ----------------------------------------------

        Dear Sirs:

             I am General Counsel to Thermo Electron Corporation (the
        "Company") and have acted as counsel in connection with the
        registration under the Securities Act of 1933, as amended (the
        "Act"), on Form S-3 of 5,000,000 shares of the Company's Common
        Stock, par value $1.00 per share (the "Shares"), which may from
        time to time be delivered by Thermo Instrument Systems
        Inc.("Thermo Instrument"), the Company's 81% owned subsidiary, to
        holders of the 4 1/2% Senior Convertible Debentures due 2003
        issued by Thermo Instrument(the "Debentures")upon conversion of
        the Debentures. Thermo Electron Corporation has agreed to sell
        the Shares to Thermo Instrument solely for purposes of allowing
        Thermo Instrument to deliver the Shares upon such conversions.

             I or members of my staff have reviewed the corporate
        proceedings taken by the Company with respect to the
        authorization of the issuance of the Shares.  I or members of my
        staff have also examined and relied upon the originals or copies,
        certified or otherwise authenticated to our satisfaction, of all
        corporate records, documents, agreements or other instruments of
        the Company and have made all investigations of law and have
        discussed with the Company's representatives all questions of
        fact as deemed necessary or appropriate.
PAGE
<PAGE>


        Page 2



             Based upon and subject to the foregoing, I am of the opinion
        that the Shares have been duly authorized by the Company and when
        sold by the Company to Thermo Instrument pursuant to the terms of
        the Agreement dated as of October 10, 1996 between the Company
        and Thermo Instrument and filed as Exhibit 99 to the Registration
        Statement, will be validly issued, fully paid and non-assessable.

             Pursuant to the requirements of the Act, I hereby consent to
        the filing of this opinion as Exhibit 5 to the Registration
        Statement, including any amendments thereto, and to the use of my
        name under the caption "Legal Opinion" in the prospectus
        constituting a part thereof.

                                           Very truly yours,


                                           Seth H. Hoogasian
                                           General Counsel











                               ARTHUR ANDERSEN LLP


                                                             Exhibit 23.1


                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


             As independent public accountants, we hereby consent to the
        incorporation by reference in this registration statement on Form
        S-3 of Thermo Electron Corporation of our reports dated February
        15, 1996 (except with respect to the matters discussed in Note 16
        as to which the date is June 28, 1996) included in Thermo
        Electron Corporation's annual report on Form 10-K for the fiscal
        year ended December 30, 1995 and to all references to our Firm
        included in this Registration Statement.



                                                ARTHUR ANDERSEN LLP


                                                /s/Arthur Andersen LLP


        Boston, Massachusetts








                                                               Exhibit 99

                                    AGREEMENT


             This Agreement is made as of the 10th day of October 1996
        between Thermo Electron Corporation, a Delaware corporation (the
        "Company"), and Thermo Instrument Systems Inc., a Delaware
        corporation ("THI").

                                    RECITALS

             The Company currently files consolidated U.S. federal tax
        returns with THI.  The Company may continue to consolidate U.S.
        federal tax returns with THI provided that the Company
        continuously maintains ownership of at least 80% of THI's
        outstanding Common Stock.  If the Company owns at any time less
        than 80% of THI's outstanding Common Stock, THI would be required
        to file a separate U.S. federal tax return.  This deconsolidation
        could have a significant adverse impact on the Company.

             THI has proposed to issue up to $200 million principal
        amount of senior convertible debentures (the "Debentures"), to be
        guaranteed by the Company.  The Board of Directors believes that
        the issuance of the Debentures by THI is in the best interests of
        the Company and THI.  However, conversion of these debentures
        into THI Common Stock would increase the number of shares of THI
        Common Stock outstanding, thereby diluting the Company's
        ownership of THI, potentially below 80%.  To allow THI to issue
        the Debentures, while protecting the ability of the Company and
        THI to consolidate for U.S. federal tax purposes, the Board of
        Directors of the Company believes that it is in the best interest
        of the Company and THI to incorporate in the Debentures an option
        that permits the delivery by THI of shares of the Company's
        Common Stock upon conversion of Debentures, in lieu of shares of
        THI Common Stock otherwise issuable upon such conversion (the
        "Settlement Option").  To facilitate THI's exercise of such
        option, the Board of Directors of the Company has authorized the
        issuance of up to 5,000,000 shares of the Company's Common Stock
        (the "Shares").

             NOW, THEREFORE, the parties hereto hereby agree as follows:

             1.   Notice from THI.  The Company shall sell Shares to THI
                  ---------------
        on any one or more occasions if THI determines that the purchase
        of such Shares is needed to allow THI to exercise the Settlement
        Option.  THI may offer to purchase Shares by delivering a notice
        to the Chief Financial Officer and the Secretary of the Company,
        specifying the number of Shares that THI desires to purchase.
        The offer to purchase Shares by THI shall be irrevocable and
        shall be deemed accepted by the Company upon its receipt thereof.
        The date upon which the Company receives such notice is referred
        to herein as the "Notice Date."
PAGE
<PAGE>


                                        2


             2.   Purchase Price.  The purchase price for any Shares sold
                  --------------
        under this Agreement shall equal the average of the closing
        prices for the Company's Common Stock on the New York Stock
        Exchange for the five trading days immediately preceding the
        Notice Date.  On the Notice Date, THI shall deliver the purchase
        price for the Shares to the Company by check or other method
        acceptable to the Company.  The Company shall deliver to THI a
        certificate representing the purchased Shares in such name or
        names as THI shall request as soon as practicable following the
        Notice Date.

             3.   Listing.  No Shares may be issued or sold under this
                  -------
        Agreement unless and until such Shares have  been accepted for
        listing on the New York Stock Exchange.  The Company shall use
        its best efforts to effect such listing prior to January 1, 1997.

             4.   Registration.  The delivery of the Shares to holders of
                  ------------
        Debentures upon THI's exercise of the Settlement Option shall be
        registered by the Company under the Securities Act of 1933 (the
        "Act").  The Company shall use its best efforts to cause such
        registration to become effective prior to January 1, 1997.  The
        Company shall indemnify and hold harmless THI and its directors,
        officers and employees against all losses, claims or damages to
        which they may become subject insofar as such losses, claims or
        damages arise out of or are based upon (i) any untrue statement
        or alleged untrue statement of a material fact contained in the
        registration statement pertaining to the Shares or (ii) any
        omission or alleged omission to state therein a material fact
        required to be stated therein or necessary to make the statements
        therein not misleading, unless such statements or omissions
        relate to THI.

             5.   Adjustment.  If, as a result of any stock dividend,
                  ----------
        stock split, reverse stock split or other similar transaction,
        the number of outstanding shares of Company Common Stock is
        increased or decreased, then an appropriate and proportionate
        adjustment shall be made in the number of Shares subject to this
        Agreement.

             6.   Term.   This Agreement shall be effective until the
                  ----
        sooner to occur of (i) October 15, 2003 or (ii) five business
        days following the date upon which the Debentures are redeemed by
        the Company.

             7.   Amendment.  This Agreement may be amended only by the
                  ---------
        written agreement of the Company and THI.

        THERMO ELECTRON CORPORATION        THERMO INSTRUMENT SYSTEMS INC.

        By: /s/ John N. Hatsopoulos   By:  /s/  Jonathan W. Painter
            -----------------------       -----------------------------
            Name:  John N. Hatsopoulos     Name: Jonathan W. Painter



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission